Health
Donor stem cell transplant can improve survival rates for older patients with MDS, study shows – News-Medical.Net
A new clinical trial offers the most compelling evidence to date that a donor stem cell transplant can improve survival rates for older patients with higher-risk…
A new clinical trial offers the most compelling evidence to date that a donor stem cell transplant can improve survival rates for older patients with higher-risk myelodysplastic syndrome (MDS), Dana-Farber Cancer Institute investigators report at the virtual 62nd American Society of Hematology (ASH) Annual Meeting.
Despite being the only current cure for MDS and widely used for younger patients, transplant generally hasn’t been offered to older patients because it has not been proven beneficial…
-
General19 hours agoQueensland government expands youth justice laws, David Crisafulli tells UN critics ‘you don’t control me’
-
General22 hours agoRestaurants on the brink as business failures plateau
-
General19 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore
-
General22 hours agoRegional house price growth outstrips capital cities